Product Information

MONTELUKAST SOD 4 MG TAB CHEW is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0784 per EA under NDC 57237021290. Its NADAC has been published 562 times since Feb 10, 2016.

FDA first approved this application on Aug 3, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MONTELUKAST SOD 4 MG TAB CHEW

Montelukast Sodium
$0.0784per EA

Strength

4 mg/1

NDC

57237021290

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MONTELUKAST SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA202096

FDA Approved

8/3/2012

TE Code

AB

On Market Since

8/3/2012

Pharmacological Classes

Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for MONTELUKAST SOD 4 MG TAB CHEW has been published 562 times since Feb 10, 2016, and over the history we have for it it has declined 72.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0784 per EA
All-time high$0.2871 (Aug 10, 2016)
All-time low$0.0659 (Nov 20, 2024)
52-week high$0.0840
52-week low$0.0689
Median price$0.1038
Average price$0.1230
Largest weekly change+27.1% (Jun 19, 2024)
Weeks tracked562
Tracking sinceFeb 10, 2016

Price History

1W

0.0%

1M

+4.1%

3M

+13.8%

6M

+3.7%

1Y

-6.6%

3Y

-5.8%

5Y

-25.3%

All

-72.2%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MONTELUKAST SOD 4 MG TAB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 4 MG TAB CHEW, manufactured by Rising Pharma Holdings Inc., is $0.0784 per EA (NDC 57237021290), effective Nov 11, 2026.

How has the price of MONTELUKAST SOD 4 MG TAB CHEW changed over time?

Over the history we have for it, the NADAC for MONTELUKAST SOD 4 MG TAB CHEW has declined 72.2%. It has been tracked across 562 weekly CMS publications since Feb 10, 2016.

What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 4 MG TAB CHEW?

Since Feb 10, 2016, the NADAC for MONTELUKAST SOD 4 MG TAB CHEW has ranged from a low of $0.0659 (Nov 20, 2024) to a high of $0.2871 (Aug 10, 2016), with a median of $0.1038 per EA.

Are there cheaper alternatives to MONTELUKAST SOD 4 MG TAB CHEW?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MONTELUKAST SOD 4 MG TAB CHEW in a comparable dosage form, but none are currently priced below it.

Who manufactures MONTELUKAST SOD 4 MG TAB CHEW?

MONTELUKAST SOD 4 MG TAB CHEW (NDC 57237021290) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.